Regeneron says U.S. government to buy 1.25 million doses of its COVID-19 treatment


Regeneron Pharmaceuticals Inc. REGN, +0.84% said late Tuesday that the U.S. government has agreed to buy an additional 1.25 million doses of the company's COVID-19 antibody cocktail. That would bring the U.S. supply of the cocktail, consisting of casirivimab and imdevimab antibodies, to more than 1.5 million doses. Under the new agreement, the government will purchase all finished doses of the cocktail delivered by June 30.


To know more, read the full article right here.

0 comments